Autolus will evaluate Cellares’ fully automated, high-throughput manufacturing platform in preparation for expansion into new indicationsSOUTH SAN FRANCISCO, Calif. and LONDON, Jan. 06, 2026 (GLOBE ...
Autolus Therapeutics, a commercial-stage biopharmaceutical company, has announced plans to assess the feasibility of Cellares ...
Manufacturing platforms for cell and gene therapies (CGT) are becoming more automated and integrated but, despite recent gains, there’s still a lot of room for improvement. The challenge is that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback